Similar to the full-length SEPT9, nearly a third (~35%) of all N-terminal mutations are found in intestinal cancer samples and approximately 10% are cataloged under skin, stomach or endometrial cancers (Figure 8A). The gene discussed is SEPTIN9; the disease is intestinal cancer.